Blood cancers
This is a list of conditions we currently have research studies for. Click to reveal more.
Polcythemia vera (PV)
MITHRIDATE
What is the study about?
The aim of this research study is to test how safe and effective a drug called ruxolitinib is when treating patients with PV when compared to the current Best Available Therapy (BAT).
Who can take part?
People with high risk PV
How do I take part?
Please discuss with your doctor at your next clinic appointment.
More information
Visit the study website.
Myeloid Leukaemia
PROPEL
What is the study about?
Treatment for Acute Myeloid Leukaemia (AML) and Myelodysplastic syndrome with excess blasts (MDS-EB2) is extremely challenging and patients often feel very tired (fatigued) have low mood, poor nutrition and be unable to do any exercise. Programmes that help patients improve their overall health and fitness before major treatment is called prehabilitation. This study aims to see if a personalised prehabilitation package which includes remote support for emotional wellbeing, nutrition and exercise can help patients get through all cycles of intensive chemotherapy and stem cell transplant (if given), as well as reduce tiredness, improve quality of life, and treatment outcomes for patients with AML and MDS-EB2.
Who can take part?
People who have been diagnosed with AML or MDS with excess blasts and are, or their blood results suggest they are likely to be in remission after induction chemotherapy. They will also be planning to undertake consolidation chemotherapy with or without a stem cell transplant.
How do I take part?
Please ask at your next clinic appointment.
Myeloma
About
The study will investigate precision medicine approaches to allocate treatment to patients based on the genetics (changes in the genes) of their myeloma and their myeloma’s response to initial treatment. This allows a more personalised approach to treatment rather than the ‘one size fits all’ approach offered as the current standard of care
Can I take part?
Newly diagnosed multiple myeloma patients who are suitable for a stem cell transplant
More information
Please visit Cancer Research UK [external] for more information about this study.
Follicular lymphoma
PETReA Plus: Prospective observational study of treatment & outcomes for patients with newly diagnosed follicular lymphoma
What is this study about?
This trial is collecting long term information people newly diagnosed with follicular lymphoma who are due to start treatment.
Who can take part?
Adults with grade 1, 2, 3A or 3B follicular lymphoma who have had a diagnostic biopsy within the last 6 months and have any planned treatment (including watch and wait) may be eligible for this trial.
What is involved?
The trial will enrol all people with newly diagnosed follicular lymphoma who are receiving their first treatment. Data will be collected during the patient’s clinic visits. Other than quality of life (QoL) questionnaires, no extra tests or assessments will be carried out.
Tell me more
Please visit the trial website here [external].
How do I take part?
Please ask at your next clinic appointment.